<DOC>
	<DOCNO>NCT01734811</DOCNO>
	<brief_summary>The purpose study evaluate efficacy biological vaccine prevent episodes bronchospasm , induced recurrent respiratory tract infection , child , compare placebo group .</brief_summary>
	<brief_title>Efficacy Safety Evaluation Recurrent Bronchospasms</brief_title>
	<detailed_description>Double blind parallel placebo control study . The subject receive medication 6 month follow another six month .</detailed_description>
	<mesh_term>Bronchial Spasm</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects whose parent /legal representative give write informed consent . Both gender Subject 36 month age . Subjects recurrent bronchospasm ; 3 exacerbation last 12 month Subjects whose parents/legal representative give write informed consent . Subjects age range Subjects malignancies chemotherapy treatment Subjects include another clinical trial last 12 month . Subject immunosuppressive immunostimulatory treatment Subjects receive iv gamma globulin past 12 month . Subjects diagnose candidiasis fungal recurrent infection . Subjects diagnosed malabsorption syndrome Subjects clinical allergy common aeroallergens geographical area . Subjects hepatitis virus infection , HIV tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Bronchospasm</keyword>
</DOC>